Abstract
Introduction
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare and recently described type of peripheral T-cell lymphoma. Fewer than 550 cases have been reported worldwide. Although BIA-ALCL is usually indolent, early diagnosis and treatment have been shown to improve outcome.
Case Description
This case report describes the management of a 50-year-old healthy Caucasian woman presenting with rapid painful enlargement of the left breast. Imaging revealed findings consistent with BIA-ALCL. This diagnosis was confirmed by fine needle aspiration cytology and subsequent pathological analysis. Bilateral removal of implants, complete left capsulectomy and immediate bilateral implant exchange were performed.
Conclusion
No consensus currently exists regarding optimal time of implant exchange and management of the contralateral capsule. The immediate replacement with smooth implants was thoroughly discussed with the patient and endorsed by expert opinion, given complete removal of the disease. There was no sign of recurrence at 6 months. Close clinical and radiological visits are planned for the next years.
Level of Evidence V
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–2390
Jacobsen E (2006) Anaplastic large-cell lymphoma, T-/null-cell type. Oncologist 11(7):831–840
Clemens MW, Jacobsen E. Breast implant-associated anaplastic large cell lymphoma [Document on the internet]. UpToDate; 19 April 2017 [Cited 2017 October 13]. https://www.uptodate.com/contents/breast-implant-associated-anaplastic-large-cell-lymphoma?search=bia%20alcl&source=search_result&selectedTitle=1~7&usage_type=default&display_rank=1
Keech JA Jr, Creech BJ (1997) Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg 100(2):554–555
United States. U.S. Food and Drug Administration (2017) Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). [Document on the internet]. U.S. FDA: BIA-ALCL; 2017 [cited 2017 October 13]. https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm239995.htm. Accessed 15 Oct 2017
Olack B, Gupta R, Brooks GS (2007) Anaplastic large cell lymphoma arising in a saline breast implant capsule after tissue expander breast reconstruction. Ann Plast Surg 59(1):56–57
Lazzeri D, Agostini T, Bocci G et al (2011) ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity. Clin Breast Cancer 11(5):283–296
Leberfinger AN, Behar BJ, Williams NC, Rakszawski KL, Potochny JD, Mackay DR et al (2017) Breast implant-associated anaplastic large cell lymphoma: a systematic review. JAMA Surg 152(12):1161–1168
Loch-Wilkinson A, Beath KJ, Knight RJW, Wessels WLF, Magnusson M, Papadopoulos T et al (2017) Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg 140(4):645–654
Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S et al (2016) Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Oncol 34(2):160–168
Clemens MW, Brody GS, Mahabir RC, Miranda RN (2018) How to diagnose and treat breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg 141(4):586e–599e
National Comprehensive Cancer Network. About NCCN. www.nccn.org/about. Accessed 10 Nov 2017
Clemens MW, Horwitz SM (2017) NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J 37(3):285–289
Miranda RN, Aladily TN, Prince HM, Kanagal-Shamanna R, de Jong D, Fayad LE et al (2014) Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol 32(2):114–120
Alhamad S, Guerid S, El Fakir EH, Biron P, Tourasse C, Delay E (2016) Breast implant-associated anaplastic large cell lymphoma. Case report of an undiagnosed form, management and reconstruction (ALCL). Ann Chir Plast Esthet 61(3):223–230
Acknowledgements
The authors would like to thank Dr. Mark W. Clemens of the MD Anderson Cancer Center for his valued advice regarding BIA-ALCL and contribution to this report. The authors would also like to acknowledge Dr. Tony Petrella for his generous contribution in the histopathological analysis of this case.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human and Animal Rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Shine, J.J., Boghossian, E., Beauchemin, G. et al. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Immediate or Delayed Implant Replacement?. Aesth Plast Surg 42, 1492–1498 (2018). https://doi.org/10.1007/s00266-018-1204-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-018-1204-0